Isolation, cultivation and identification of human lung adenocarcinoma stem cells

Oncology Letters

Volumn 9, Issue 1, 2015, Pages 47-54

  Zhang, De Geng ^a   Jiang, Ai Gui ^a   Lu, Hui Yu ^a   Zhang, Li Xin ^a   Gao, Xiao Yan ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Cell separation; Cluster of differentiation 133; Lung cancer; Lung cancer stem cell

Indexed keywords

CD133 ANTIGEN; CELL SURFACE MARKER; CISPLATIN; CYTOKERATIN 18; CYTOKERATIN 8; GEMCITABINE;

ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL RENEWAL; CELL SELECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

EID: 84911398152     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2639     Document Type: Article

References (29)

1. Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83: 584-594, 2008.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Yang L, Parkin DM, Ferlay J, Li L and Chen Y: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14: 243-250, 2005.
4. Zhou XD, Wang XY, Qu FJ, et al: Detection of cancer stem cells from the C6 glioma cell line. J Int Med Res 37: 503-510, 2009.
5. Qiu B, Zhang D, Tao J, Wu A and Wang Y: A simplified and modified procedure to culture brain glioma stem cells from clinical specimens. Oncol Lett 3: 50-54, 2012.
6. Hwang-Verslues WW, Kuo WH, Chang PH, et al: Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One 4: e8377, 2009.
7. Chen W and Wang GM: Gene expression profiling of cancer stem cells in the Du145 prostate cancer cell line. Oncol Lett 3: 791-796, 2012.
8. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110, 2007.
9. Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T and Moriwaki H: Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351: 820-824, 2006.
10. Varnat F, Duquet A, Malerba M, et al: Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 1: 338-351, 2009.
11. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer and cancer stem cells. Nature 414: 105-111, 2001.
12. Sullivan JP, Minna JD and Shay JW: Evidence for self-renewing lung cancer stem cells and their implications in tumour initiation, progression, and targeted therapy. Cancer Metastasis Rev 29: 61-72, 2010.
13. Otto WR: Lung epithelial stem cells. J Pathol 197: 527-535, 2002.
14. Rawlins EL and Hogan BL: Epithelial stem cells of the lung: privileged few or opportunities for many? Development 133: 2455-2465, 2006.
15. Shi Y, Fu X, Hua Y, Han Y, Lu Y and Wang J: The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells. PLoS One 7: e33358, 2012.
16. Meng M, Zhao XH, Ning Q, Hou L, Xin GH and Liu LF: Tumor stem cells: A new approach for tumor therapy (Review). Oncol Lett 4: 187-193, 2012.
17. Kim CF, Jackson EL and Woolfenden AE, et al: Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835, 2005.
18. Ho MM, Ng AV, Lam S and Hung JY: Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827-4833, 2007.
19. Eramo A, Lotti F and Sette G, et al: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514, 2008.
20. Groome PA, Bolejack V, Crowley JJ, et al; IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions: The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM clas-sification of malignant tumors. J Thorac Oncol 2: 694-705, 2007.
21. Dong QG, Yao M, Geng Q, Zhou J and Yan MX: Isolation and identification of human lung adenocarcinoma stem cells. Tumor 28: 1-7, 2008 (In Chinese).
22. Bertolini G, Roz L, Perego P, et al: Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 106: 16281-16286, 2009.
23. Dean M: ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia 14: 3-9, 2009.
24. Sung JM, Cho HJ, Yi H, et al: Characterization of stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun 371: 163-167, 2008.
25. Levina V, Marrangoni AM, DeMarco R, Gorelik E and Lokshin AE: Drug-selected human lung cancer stem cells: cytokine network,tumorigenic and metastatic properties. PLoS One 3: e3077, 2008.
26. Omary MB, Coulombe PA and McLean WH: Intermediate filament proteins and their associated diseases. New Engl J Med 351: 2087-2100, 2004.
27. Fukunaga Y, Bandoh S, Fujita J, et al: Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients. Lung Cancer 38: 31-38, 2002.
28. Kanaji N, Bandoh S, Fujita J, Ishii T, Ishida T and Kubo A: Compensation of type I and type II cytokeratin pools in lung cancer. Lung Cancer 55: 295-302, 2007.
29. Ghotra VP, Puigvert JC and Danen EH: The cancer stem cell microenvironment and anti-cancer therapy. Int J Radiat Biol 85: 955-962, 2009.